Imagine being able to keep your malignant mesothelioma from spreading with a simple injection, in much the same way that you were protected from polio and measles. That is exactly what scientists from Stanford University are working towards as they continue researching a new stem cell vaccine.
According to research published in the scientific journal Cell, scientists have been examining anti-tumor responses that they were able to facilitate by injecting a stem cell vaccine into laboratory animals infected with malignant mesothelioma, breast cancer, and melanoma. The vaccine is made from iPS cells that were sourced from skin and blood. These iPS cells, which are also known as pluripotent stem cells, were then manipulated in a way that stripped them of the genetic programming that originally told them what type of cells to develop into, then injected into the infected animals. The result was an upgrade to the animals’ immune system that made them better able to respond to the presence of their tumors and to stop new ones from forming.
Stem cells have been praised for their potential in the treatment of numerous illnesses and disabilities, and their use in treating a rare condition like malignant mesothelioma that has proven to be so resistant to traditional medications is extremely encouraging. According to lead study author Nigel Korean, MD, “These cells, as a component of our proposed vaccine, have strong immunogenic properties that provoke a systemwide, cancer-specific immune response. We believe this approach has exciting clinical potential.” Senior author Joseph Wu, MD, PhD expanded on these thoughts, saying, “Although much research remains to be done, the concept itself is pretty simple. We would take your blood, make iPS cells and then inject the cells to prevent future cancers. I’m very excited about the future possibilities.”
The idea of stopping mesothelioma in its tracks offers real hope for patients diagnosed with this rare and deadly disease. For information on other ways that you can battle your situation, contact us today at 1-800-966-2244.